Skip to main content

Table 2 Comparison between patients and controls

From: Pulmonary hypertension in patients with Martorell hypertensive leg ulcer: a case control study

Δ P systolic RV / RA – mmHg (± SD)

33.8 (± 16.9)

25.3 (± 6.5)

p = 0.023

Pulmonary hypertension (sPAP > 36 mmHg) – no. (%)

5 (36%)

2 (7%)

p = 0.031

Left ventricular ejection fraction – % (± SD)

62 (± 3)

58 (± 12)

ns

Left atrial diameter (ESD)– cm (± SD)

4.47 (± 1.05)

4.35 (± 0.80)

ns

Right atrial diameter (ESD) long axis – cm (± SD)

5.20 (± 1.04)

5.08 (± 0.83)

ns

Right atrial diameter (ESD) short axis – cm (± SD)

3.84 (± 0.80)

3.72 (± 0.75)

ns

E / A ratio – mean (± SD) *

0.90 (± 0.23)

0.91 (± 0.37)

ns

Significant valvular heart disease – no. (%) †

3 (21%)

5 (17%)

ns

Creatinine level – μmol/l (± SD)

109 (± 51)

104 (± 42)

ns

GFR estimated by MDRD – ml/min (± SD)

64 (± 37)

59 (± 19)

ns

Body Mass Index (BMI) – kg/m2 (± SD)

29.57 (± 7.08)

25.84 (± 5.07)

p = 0.036

  1. * E / A ratio could not be assessed due to atrial fibrillation in 5 of 14 patients and in 8 of 28 controls.
  2. † Mitral insufficiency in 1 of 14 patients and 3 of 28 controls; severe aortic stenosis in 2/14 and 2/28, respectively.